Congo Battles Fastest-Growing Ebola Outbreak with Expanded Vaccine Rollout

The Democratic Republic of Congo is experiencing its fastest-growing Ebola outbreak on record. To combat this, Merck & Co.'s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use.

The move comes as the outbreak worsens in eastern DR Congo. The Merck vaccine has already been used to some extent in the region, but its distribution is now being expanded. Meanwhile, the Gilead drug will be deployed to treat patients who have contracted Ebola.

No specific details are given about when or how these measures will be implemented. However, it's clear that the international community is taking a more aggressive approach to combatting this outbreak.